[EN] PHTALAZINONE DERIVATIVES AS MPEGS -1 INHIBITORS<br/>[FR] DÉRIVÉS DE PHTALAZINONE EN TANT QU'INHIBITEURS DE MPGES-1
申请人:GLENMARK PHARMACEUTICALS SA
公开号:WO2013072825A1
公开(公告)日:2013-05-23
The present patent application is directed to bicyclic compounds of formula (I) or pharmaceutically acceptable salt thereof as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (m PGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.
本专利申请涉及公式(I)的双环化合物或其药用盐,作为mPGES-1抑制剂。这些化合物是微粒体前列腺素E合成酶-1(mPGES-1)酶的抑制剂,因此在治疗多种疾病或情况引起的疼痛和/或炎症方面非常有用,如哮喘、骨关节炎、类风湿性关节炎、急性或慢性疼痛和神经退行性疾病。